EUVIMEDEUVIMED entdecken
Open Access

Deciphering KDM8 dysregulation and CpG methylation in hepatocellular carcinoma using multi-omics and machine learning

Firoz Ahmed iD, Nitish Kumar Mishra iD, Othman A Alghamdi iD, Mohammad Imran Khan iD, Aamir Ahmad iD, Nargis Khan iD, Mohammad Rehan iD

Epigenomics · 2024

DOI: 10.1080/17501911.2024.2374702 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epigenomics, 2024. Verfasst von Firoz Ahmed und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, College of Science, University of Jeddah, Jeddah, Saudi Arabia. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, DNA Methylation, Machine Learning. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: University of Jeddah.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

This study investigates the altered expression and CpG methylation patterns of histone demethylase KDM8 in hepatocellular carcinoma (HCC), aiming to uncover insights and promising diagnostics biomarkers.Materials & methods: Leveraging TCGA-LIHC multi-omics data, we employed R/Bioconductor libraries and Cytoscape to analyze and construct a gene correlation network, and LASSO regression to develop an HCC-predictive model.

Results

In HCC, KDM8 downregulation is correlated with CpGs hypermethylation. Differential gene correlation analysis unveiled a liver carcinoma-associated network marked by increased cell division and compromised liver-specific functions. The LASSO regression identified a highly accurate HCC prediction signature, prominently featuring CpG methylation at cg02871891.

Conclusion

Our study uncovers CpG hypermethylation at cg02871891, possibly influencing KDM8 downregulation in HCC, suggesting these as promising biomarkers and targets. Changes in gene function can play a role in causing cancer. In this study, we looked at how a specific gene called KDM8 behaves in liver cancer. By analyzing a large set of liver cancer samples, we investigated how gene interactions are different in this disease and if they can help predict liver cancer risk. Our results show that the KDM8 gene is less active, and its DNA gets chemically modified more often in liver cancer. We also found a group of genes and DNA changes, which are linked to the disease. Using this information, we identified 16 important markers and built a computer model that can accurately predict liver cancer. We found that DNA methylation at a specific spot called cg02871891 is especially important for predicting liver cancer. Overall, our study suggests that high levels of DNA methylation may lead to reduced KDM8 activity in liver cancer, which could be important for future research and better diagnostic tools.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsDNA MethylationMachine LearningCpG IslandsGene Expression Regulation, NeoplasticHumansBiomarkers, TumorHistone DemethylasesGene Regulatory NetworksMultiomics

Stichwörter der Autor:innen

DNA methylationLASSO modelTCGAbioinformaticsbiomarkersgene expressionliver cancerregulatory network

Substanzen

Biomarkers, TumorHistone Demethylases

Autor:innen und Institutionen

  • Department of Biological Sciences, College of Science, University of Jeddah, Jeddah, Saudi Arabia.
  • Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN, 38015, USA.
  • Research Center, King Faisal Specialist Hospital & Research Centre, Jeddah, Saudi Arabia.
  • Department of Biochemistry & Molecular Medicine, College of Medicine, Al-Faisal University, Riyadh, Saudi Arabia.
  • Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, 3050, Qatar.
  • Snyder Institute of Chronic Diseases, Health Research & Innovation Center, Cumming School of Medicine, University of Calgary, Alberta, Canada.

ORCID-Profile: Firoz Ahmed, Nitish Kumar Mishra, Othman A Alghamdi, Mohammad Imran Khan, Aamir Ahmad, Nargis Khan, Mohammad Rehan

Förderung

  • University of Jeddah

Zitieren

APA

Ahmed, F., Mishra, N. K., Alghamdi, O. A., Khan, M. I., Ahmad, A., Khan, N., & Rehan, M. (2024). Deciphering KDM8 dysregulation and CpG methylation in hepatocellular carcinoma using multi-omics and machine learning. Epigenomics. https://doi.org/10.1080/17501911.2024.2374702

Vancouver

Ahmed F, Mishra NK, Alghamdi OA, Khan MI, Ahmad A, Khan N, et al. Deciphering KDM8 dysregulation and CpG methylation in hepatocellular carcinoma using multi-omics and machine learning. Epigenomics. 2024. doi:10.1080/17501911.2024.2374702

BibTeX
@article{Ahmed2024,
  author = {Ahmed, Firoz and Mishra, Nitish Kumar and Alghamdi, Othman A and Khan, Mohammad Imran and Ahmad, Aamir and Khan, Nargis and Rehan, Mohammad},
  title = {Deciphering KDM8 dysregulation and CpG methylation in hepatocellular carcinoma using multi-omics and machine learning},
  journal = {Epigenomics},
  year = {2024},
  doi = {10.1080/17501911.2024.2374702}
}
Kostenlos starten →